Page 52 - ARNM-2-4
P. 52

Advances in Radiotherapy
            & Nuclear Medicine                                             Outcomes of durations in 2D and 3D BT for CCA



               for cervix cancer.  Int  J  Radiat  Oncol  Biol  Phys.   of patient and system factors on the radiotherapy treatment
               2019;103(5):1088-1097.                             time in the treatment of non-metastatic cervical cancer
                                                                  patients in a rural and resource-lean state’s safety-net hospital:
               doi: 10.1016/j.ijrobp.2018.11.012
                                                                  Benefits of strategic planning. Cureus. 2023;15(3):e35954.
            20.  Kim YJ, Kang HC, Kim YS. Impact of intracavitary      doi: 10.7759/cureus.35954
               brachytherapy technique (2D versus 3D) on outcomes of
               cervical cancer: A  systematic review and meta-analysis.   26.  Dereje N, Addissie A, Worku A, et al. Association between
               Strahlenther Onkol. 2020;196(11):973-982.          waiting time for radiotherapy initiation and disease
                                                                  progression among women with cervical cancer in Addis
               doi: 10.1007/s00066-020-01658-0
                                                                  Ababa, Ethiopia. Int J Cancer. 2021;149(6):1284-1289.
            21.  Girinsky T, Rey A, Roche B, et al. Overall treatment time
               in advanced cervical carcinomas: A  critical parameter      doi: 10.1002/ijc.33689
               in treatment outcome.  Int J Radiat Oncol Biol Phys.   27.  Nascimento MI,  Silva  GA. Effect  of waiting time for
               1993;27(5):1051-1056.                              radiotherapy on five-year overall survival in women
                                                                  with cervical cancer, 1995-2010.  Cad Saude Publica.
               doi: 10.1016/0360-3016(93)90522-w
                                                                  2015;31(11):2437-2448.
            22.  Lanciano RM, Pajak TF, Martz K, Hanks GE. The influence      doi: 10.1590/0102-311x00004015
               of treatment time on outcome for squamous cell cancer of
               the uterine cervix treated with radiation: A patterns-of-care   28.  Tanderup  K, Nesvacil N, Kirchheiner K,  et al. Evidence-
               study. Int J Radiat Oncol Biol Phys. 1993;25(3):391-397.  based dose planning aims and dose prescription in image-
                                                                  guided brachytherapy combined with radiochemotherapy
               doi: 10.1016/0360-3016(93)90058-4
                                                                  in  locally  advanced  cervical  cancer.  Semin Radiat Oncol.
            23.  Chatani M, Matayoshi Y, Masaki N, Inoue T. High-dose rate   2020;30(4):311-327.
               intracavitary irradiation for carcinoma of the uterine cervix.
               The adverse effect of treatment prolongation.  Strahlenther      doi: 10.1016/j.semradonc.2020.05.008
               Onkol. 1997;173(7):379-384.                     29.  Liu Z, Zhao Y, Li Y,  et al. Imaging-guided brachytherapy
                                                                  for locally advanced cervical cancer: The main process and
               doi: 10.1007/BF03038241
                                                                  common techniques. Am J Cancer Res. 2020;10(12):4165-4177.
            24.  Vitzthum L, Yuan J, Jones D, Boldt A, Dusenbery K.   30.  Van Leeuwen CM, Oei AL, Chin K,  et al.  A  short time
               Reducing prolonged chemoradiation treatment times for   interval between radiotherapy and hyperthermia reduces
               cervical cancer. Bmj Open Quality. 2019;8(3):e000516.
                                                                  in-field recurrence and mortality in women with advanced
               doi: 10.1136/bmjoq-2018-000516                     cervical cancer. Radiat Oncol. 2017;12(1):75.
            25.  Vijayakumar S, Nittala MR, Duggar WN, et al. The influence      doi: 10.1186/s13014-017-0813-0



































            Volume 2 Issue 4 (2024)                         12                             doi: 10.36922/arnm.4310
   47   48   49   50   51   52   53   54   55   56   57